Abbott to separate global nutrition business
Abbott to separate global nutrition business Oct 21 (Reuters) - Abbott Laboratories ABT.N said on Wednesday it plans to separate its nutrition business into an independent, publicly traded company.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
Recent news on Abbott Laboratories
See all newsBrief: Abbott Announces Availability Of Panbio Covid-19/Flu A&B Self-Test In Canada
Perrigo to sell infant formula business to MeridianMade for up to $175 million
Brief: Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve Disease
Corrected: German startup NVision shows new path to quantum computing chips in Nature paper
Brief: Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve Replacement